[Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results].

Advances in gerontology = Uspekhi gerontologii2013PMID: 24003726

Plain Language Summary

This review summarized long-term clinical studies on peptide bioregulators including epithalamin, examining their efficacy in disease prevention and treatment across different age groups. Special emphasis was placed on the geroprotective (anti-aging) potential of these peptide preparations.

Abstract

The review summarizes the results of long-term studies of the authors on the clinical efficacy of peptide bioregulators (Timalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin) for the prevention of diseases and treatment of people of different age. Special attention is given to the analysis of the use of peptide bioregulators as geroprotectors.

Authors

Khavinson, V Kh; Kuznik, B I; Ryzhak, G A